Showing results (141-150 of 5,175) with videos related to
Sort By:
Pageof 518
New South Wales Public Health Bulletin|June 29, 2012
An ethical framework for public health immunisation programsDavid IsaacsJournal of Studies on Alcohol|May 1, 1979
College students' expectations of the results of drinkingM IsaacsThe Prostate|May 7, 2019
An IL-2 proaerolysin fusion toxin that selectively eliminates regulatory t cells to enhance antitumor immune responseOliver Rogers, Hung Yen, Anna Solomon, et al.Nature Reviews. Urology|December 21, 2022
The testosterone paradox of advanced prostate cancer: mechanistic insights and clinical implicationsRajendra Kumar, Laura A Sena, Samuel R Denmeade, et al.Oncogene|September 29, 2020
Role of androgen receptor splice variant-7 (AR-V7) in prostate cancer resistance to 2nd-generation androgen receptor signaling inhibitorsYezi Zhu, Susan L Dalrymple, Ilsa Coleman, et al.Current Opinion in Oncology|January 1, 1997
Molecular advances in prostate cancerJ T Dong, W B Isaacs, J T IsaacsCancer Research|July 1, 1979
Models for development of nonreceptor methods for distinguishing androgen-sensitive and -insensitive prostatic tumorsJ T Isaacs, W B Isaacs, D S CoffeyThe Prostate|February 23, 2017
Androgen Receptor Splice Variants Are Not Substrates of Nonsense-Mediated DecayAtinuke S Ajiboye, David Esopi, Srinivasan Yegnasubramanian, et al.The Prostate|August 8, 2022
PSA provocation by bipolar androgen therapy may predict duration of response to first-line androgen deprivation: Updated results from the BATMAN studySamuel Denmeade, Su J Lim, Pedro Isaaccson Velho, et al.The Prostate|January 1, 1990
Differential effects of growth factor antagonists on neoplastic and normal prostatic cellsR A Morton, J T Isaacs, W B IsaacsPageof 518